Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma)

NCT02887495 is registered in ClinicalTrials.gov with George Washington University as lead sponsor.

NCT NCT02887495
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02887495 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma)
Lead sponsor
George Washington University
Phase
Observational
Overall status
Completed
Start date
July 31, 2014
Completion date
February 2, 2022
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

scleroderma